Family Medicine Doctors in Stanley, ND Accepting Medicare
1 Family Medicine doctors found. Showing 1 - 1
 Mark Kenneth Longmuir, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 615 6th St Se, Stanley, ND 58784 Phone: 701-628-2424 Fax: 701-628-3274 |
News Archive
Treatment admissions for abuse of prescription pain relievers increases by over 400%: Study
The proportion of all substance abuse treatment admissions of those aged 12 and older involving abuse of prescription pain relievers rose by over 400 percent from 2.2 percent in 1998 to 9.8 percent in 2008 according to a new study be the Substance Abuse and Mental Health Services Administration (SAMHSA). This dramatic rise in the proportion of admissions associated with the abuse of these drugs occurred among nearly all segments of the population regardless of age, gender, educational level and employment status.
Study finds greater risk of suicide following initial episode of self-harm
New findings suggest that American adults who survive deliberate self-harm are at increased risk of suicide in the first year after such an event, indicating a need to direct clinical interventions in the critical 12 months following such episodes.
Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk
Elimination of the food that triggers atopic dermatitis, or eczema, is associated with increased risk of developing immediate reactions to that food, according to the results of a large-scale study recently published in the Journal of Allergy and Clinical Immunology.
Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
3SBio, Ascentage Pharma announce cancer therapeutics collaboration
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
› Verified 9 days ago